Patents by Inventor Amarylla Horvath

Amarylla Horvath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Organic compounds
    Patent number: 8263585
    Abstract: The present invention concerns a compound of formula (I) or a salt, suitably a pharmaceutically acceptable salt, or solvate thereof, wherein the groups R1, R2, Ar?, A and B are defined in the description, to compositions and use of the compounds in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: September 11, 2012
    Assignee: Novartis AG
    Inventors: Ian Bruce, Andrew Dunstan, Thomas Anthony Hunt, Catherine Howsham, Thomas Ullrich, Amarylla Horvath
  • Heteroatoms-containing tricyclic compounds
    Patent number: 7514554
    Abstract: A process for the production of 33-Epi-33-chloro-FR 520 in one step from FR520 wherein protecting groups are avoided.
    Type: Grant
    Filed: October 10, 2005
    Date of Patent: April 7, 2009
    Assignee: Novarits AG
    Inventors: Maximilian Grassberger, Amarylla Horvath
  • Acylsulfonamides as inhibitors of steroid sulfatase
    Patent number: 7482462
    Abstract: A compound of formula wherein R1 is haloalkyl, alkenyl, phenyl, thienyl, pyridine, benzthiazolyl, chromanyl (1,2-dihydrobenzopyranyl) or (C6-18)aryl, and R1 or R2 independently of each other are substituted (C4-8)cycloalkyl, a substituted bridged cycloalkyl system, substituted piperidine, substituted tetrahydropyridine, or a substituted bridged heterocyclic system, useful as a pharmaceutical.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: January 27, 2009
    Inventors: Amarylla Horvath, Philipp Lehr, Peter Nussbaumer, Erwin Paul Schreiner
  • Heteroatoms-Containing Tricyclic Compounds
    Publication number: 20080071082
    Abstract: A process for the production of 33-Epi-33-chloro-FR 520 in one step from FR520 wherein protecting groups are avoided.
    Type: Application
    Filed: October 10, 2005
    Publication date: March 20, 2008
    Inventors: Maximilian Grassberger, Amarylla Horvath
  • Acylsulfonamides as inhibitors of steroid sulfatase
    Publication number: 20050059712
    Abstract: A compound of formula wherein R1 is haloalkyl, alkenyl, phenyl, thienyl, pyridine, benzthiazolyl, chromanyl (1,2-dihydrobenzopyranyl) or (C6-18)aryl, and R1 or R2 independently of each other are substituted (C4-8)cycloalkyl, a substituted bridged cycloalkyl system, substituted piperidine, substituted tetrahydropyridine, or a substituted bridged heterocyclic system, useful as a pharmaceutical.
    Type: Application
    Filed: October 4, 2002
    Publication date: March 17, 2005
    Inventors: Amarylla Horvath, Philipp Lehr, Peter Nussbaumer, Erwin Schreiner
  • Crystalline macrolides and process for their preparation
    Patent number: 6423722
    Abstract: 33-Epichloro-33-desoxyascomycin of formula I and various tautomeric or forms thereof, in crystalline form, such as Form A and Form B. Their preparation involves appropriately converting amorphous compound of formula I, or compound of formula I in other than Form A, or compound of formula I in other than Form B, respectively, from a solution thereof under crystallization-inducing conditions or conditions inducing preferential crystallization of Form A or B, respectively. Such crystals are particularly indicated for use in the preparation of topical galenical forms of the compound for pharmaceutical use, e.g. creams, emulsions and ointments.
    Type: Grant
    Filed: October 17, 2000
    Date of Patent: July 23, 2002
    Assignee: Novartis AG
    Inventors: Cornelia Dosenbach, Maximilian Grassberger, Otto Hartmann, Amarylla Horvath, Jean-Paul Mutz, Gerhard Penn, Sabine Pfeffer, Dierk Wieckhusen